If Bill 48 is to become more than a new label on an old problem, it has to close the gaps between care, housing and accountability. That requires not just legislative change, but public measurement: ...

Our progress developing ABS-201 for androgenetic alopecia is ahead of plan as we expect to initiate a phase 1/2a trial in ...

FDA Fast Track designation -- The BRTX-100 program was granted Fast Track status by the FDA for chronic lumbar disc disease ...

Sanyou Bio and Yugong Biotoday announced the signing of a strategic cooperation agreement. This powerful alliance marks a significant step to deepen their collaboration in the development of high-end ...